Changes in editing frequencies have been described in other diseases including prostate, lung, kidney and testis tumors while reduced RNA levels of ADAR1, ADAR2 and ADAR3 have been observed in brain tumors38, 39. This evidence concerns the gene ADARB2 and neoplasm of testis.